Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M.C. de Campos
Cost-Effectiveness of Cetuximab+folfiri Versus Bevacizumab+Folfiri at the Public Healthcare System in Brazil €“ the Fire 3 Trial Economic Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
A Phase 2 Randomised Study of Veliparib Plus FOLFIRI±bevacizumab Versus Placebo Plus FOLFIRI±bevacizumab in Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Phase I Trial of FOLFIRI in Combination With Sorafenib and Bevacizumab in Patients With Advanced Gastrointestinal Malignancies.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
P16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients With Metastatic Colorectal Cancer
Cancer Research and Treatment
Cancer Research
Oncology
The Cost-Effectiveness of Bevacizumab in Advanced Ovarian Cancer Using Evidence From the ICON7 Trial
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pss25 - Cost-Effectiveness Analysis of Intravitreal Aflibercept Versus Ranibizumab in the Treatment of Diabetic Macular Edema (Dme) Under the Brazilian Public Healthcare System (Sus)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Pcv86 - Cost-Effectiveness of Sacubitril/Valsartan in the Treatment of Heart Failure Under the Brazilian Private Healthcare System Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
FOLFIRI® and Bevacizumab in First-Line Treatment for Colorectal Cancer Patients: Safety, Efficacy and Genetic Polymorphisms
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Pharmacogenetic Clinical Randomised Phase II Trial to Evaluate the Efficacy and Safety of FOLFIRI With High-Dose Irinotecan (HD-FOLFIRI) in Metastatic Colorectal Cancer Patients According to Their UGT1A 1 Genotype
British Journal of Cancer
Cancer Research
Oncology
